Zobrazeno 1 - 9 of 9 pro vyhledávání: '"M L Turbitt"'
1
The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy
Autor: R. R. Sheikh, I. Mason, M. D. Taylor, L. J. Millar, W. M. I. Evans, M. L. Turbitt, P. L. Todd
Publikováno v: Alimentary Pharmacology & Therapeutics. 12:263-271
Background: There is need for an evidence-based comparison of clinical management strategies to provide the rationale for selection of a particular therapeutic approach to treatment. Ideal dyspepsia treatment should quickly and conveniently alleviate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f813d2558462ad00d1166196982f8a4f
https://doi.org/10.1046/j.1365-2036.1998.00282.x
Zobrazit plný text záznamu
2
A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group
Autor: L M, Campbell, T J, Anderson, M R, Parashchak, C M, Burke, S A, Watson, M L, Turbitt
Publikováno v: Respiratory medicine. 93(4)
Four hundred and sixty nine patients were randomized to receive either 12 micrograms bd of eformoterol (Oxis, Astra Pharmaceuticals Ltd., Kings Langley, U.K.) delivered via Turbohaler or 50 micrograms bd salmeterol (Serevent, Glaxo-Wellcome Ltd., Uxb
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::50f95606a5a552965df5233f29de1ae6
https://pubmed.ncbi.nlm.nih.gov/10464829
Zobrazit plný text záznamu
3
The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]
Autor: I, Mason, L J, Millar, R R, Sheikh, W M, Evans, P L, Todd, M L, Turbitt, M D, Taylor
Publikováno v: Alimentary pharmacologytherapeutics. 12(3)
There is need for an evidence-based comparison of clinical management strategies to provide the rationale for selection of a particular therapeutic approach to treatment. Ideal dyspepsia treatment should quickly and conveniently alleviate patient sym
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8b648f9678c8e3f8cfce3b58989b55b5
https://pubmed.ncbi.nlm.nih.gov/9570261
Zobrazit plný text záznamu
4
Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice
Autor: A. C. Patel, R. D. Newland, C. Wilcock, J. Hole, T. L. Venables, M. L. Turbitt
Publikováno v: Scandinavian journal of gastroenterology. 32(10)
The efficacy of omeprazole, 20 mg once daily, in the treatment of reflux oesophagitis and the therapeutic advantages over the histamine H2 receptor antagonists are well documented. This study assessed 20 mg omeprazole daily (OM20), 10 mg omeprazole d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc026a9e37486f7eeba84a2f989928e
https://pubmed.ncbi.nlm.nih.gov/9361167
Zobrazit plný text záznamu
5
Two omeprazole-based Helicobacter pylori eradication regimens for the treatment of duodenal ulcer disease in general practice
Autor: G. Slatcher, M. L. Turbitt, S. A. Chesters, C. Mckinnon, M. B. Copeman, I. Mason, M. R. B. Cottrill
Publikováno v: Alimentary pharmacologytherapeutics. 11(5)
Background: Helicobacter pylori is the main acquired factor in the pathogenesis of duodenal ulcer disease. Methods: This multicentre study conducted in 32 general practice centres in the UK and Ireland was a double-blind, placebo-controlled, randomiz
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9820fff62ed52244021039b41af7a8a3
https://pubmed.ncbi.nlm.nih.gov/9354201
Zobrazit plný text záznamu
6
Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice
Autor: J. Hole, A. C. Patel, M. B. Copeman, R. D. Newland, T. L. Venables, M. L. Turbitt
Publikováno v: Scandinavian journal of gastroenterology. 32(7)
Background: Gastro-oesophageal reflux disease (GORD) is a frequent cause for consultation in general practice and is a chronically relapsing disease. Methods: This general practice study was a 6-month randomized, double-blind parallel-group placebo-c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b2b381cee040989e9d12e7f1aee39f9
https://pubmed.ncbi.nlm.nih.gov/9246699
Zobrazit plný text záznamu
7
Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma
Autor: R B Goudie, W M Buchanan, M L Turbitt, R S Patrick
Publikováno v: Journal of Clinical Pathology. 30:1124-1128
A retrospective examination in South-west Scotland of formalin-fixed paraffin-embedded liver tissue by an immunoperoxidase technique revealed hepatitis B surface antigen (HBsAg) in eight out of 81 cases (10%) of primary hepatocellular carcinoma (PHC)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3aee8dca72f5b269fef78ed76aac5a5
https://doi.org/10.1136/jcp.30.12.1124
Zobrazit plný text záznamu
8
Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions
Autor: R M Mackie, I Campbell, M L Turbitt
Publikováno v: Journal of Clinical Pathology. 37:367-372
The monoclonal antibody NK1 C3, synthesised by the Netherlands Cancer Institute, has been used to assess its value in the diagnosis of melanocytic lesions. The antigen recognised by this antibody is not denatured by formalin fixation, with the result
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5254b065c5bb547e504349e7dba5fff
https://doi.org/10.1136/jcp.37.4.367
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje